| Literature DB >> 32259536 |
Victoria J Stoj1, Jane M Grant-Kels2.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32259536 PMCID: PMC7128407 DOI: 10.1016/j.jaad.2020.03.086
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527
Estimated global COVID-19 case fatality rate distributed by age group∗
| Age, y (deaths/cases) | Case fatality rate, % (95% CI) |
|---|---|
| ≤9 (0/416) | 0 |
| 10-19 (1/549) | 0.18 (0.03-1.02) |
| 20-49 (63/19,790) | 0.32 (0.25-0.41) |
| 50-59 (130/10,008) | 1.3 (1.1-1.5) |
| 60-69 (309/8583) | 3.6 (3.2-4.0) |
| 70-79 (312/3918) | 8.0 (7.2-8.9) |
| ≥80 (208/1408) | 14.8 (13.0-16.7) |
CI, Confidence interval; COVID-19, coronavirus disease 2019.
Case fatality rate estimates are subject to change as more data becomes available. Reprinted from Oke and Heneghan.
Estimated global COVID-19 case fatality rate in patients with comorbid conditions∗
| Condition | Case fatality rate, % |
|---|---|
| Cardiovascular disease | 10.5 |
| Diabetes | 7.3 |
| Chronic respiratory disease | 6.3 |
| Hypertension | 6.0 |
| Cancer | 5.6 |
| No comorbidities | 0.9 |
COVID-19, Coronavirus disease 2019.
Case fatality rate estimates are subject to change as more data becomes available. Reprinted from Oke and Heneghan.